Related Experiment Video
Updated: Jul 18, 2026

In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing β-galactosidase
Published on: November 5, 2021
Chagas disease
A R L Teixeira1, N Nitz, M C Guimaro
1Chagas Disease Multidisciplinary Research Laboratory, Faculty of Medicine, University of Brasília, PO Box 04536 70919-970, Federal District, Brazil. ateixeir@unb.br
Insights
Chagas disease, caused by Trypanosoma cruzi, is a severe parasitic infection in Latin America. Current treatments are inadequate, leading to significant mortality from heart disease and digestive issues.
Area of Science:
- Infectious Diseases
- Parasitology
- Genetics
Background:
- Chagas disease is a significant public health concern in Latin America, affecting an estimated 18 million people.
- The disease is caused by the protozoan Trypanosoma cruzi, transmitted by triatomine insects.
- Chronic infections lead to severe morbidity and mortality, primarily through Chagas heart disease, megacolon, and megaoesophagus.
Purpose of the Study:
- To summarize the current understanding of Chagas disease.
- To highlight the high mortality and morbidity associated with chronic Trypanosoma cruzi infections.
- To underscore the limitations of current treatment options.
Main Methods:
- Review of existing field studies and epidemiological data on Trypanosoma cruzi infections.
- Analysis of reported mortality and morbidity ratios associated with Chagas disease complications.
- Examination of proposed pathogenic mechanisms, including parasite-induced genomic mutation.
Main Results:
- An estimated one-third of 18 million infected individuals in Latin America are predicted to die from Chagas disease.
- Chronic Chagas disease leads to high rates of mortality: 37.5% experience sudden death, 58% develop fatal heart failure, and 4.5% die from digestive complications.
- The pathogenesis is suspected to involve parasite-induced mutations in the vertebrate genome.
Conclusions:
- Chagas disease represents a major cause of death and disability in endemic regions.
- The current therapeutic strategies for Chagas disease are insufficient.
- Further research into pathogenesis and treatment is urgently needed.
Abstract:
Chagas disease is the clinical condition triggered by infection with the protozoan Trypanosoma cruzi. The infection is transmitted by triatomine insects while blood feeding on a human host. Field studies predict that one third of an estimated 18 million T cruzi-infected humans in Latin America will die of Chagas disease. Acute infections are usually asymptomatic, but the ensuing chronic T cruzi infections have been associated with high ratios of morbidity and mortality: Chagas heart disease leads to unexpected death in 37.5% of patients, 58% develop heart failure and die and megacolon or megaoesophagus has been associated with death in 4.5%. The pathogenesis of Chagas disease appears to be related to a parasite-induced mutation of the vertebrate genome. Currently, treatment is unsatisfactory.
Related Concept Videos
American Trypanosomiasis
Leishmaniasis
Cholera
Esophageal Achalasia
Toxoplasmosis
Giardiasis

